Business
ERMA Systems Welcomes Israel Aker, PharmD, RPh, Thermo Fisher Scientific to Advisory Board to Strengthen Medical Affairs Strategy
MIAMI, August 26, 2025--ERMA Systems, the AI-powered SaaS company transforming how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes, proudly announces the appointment of Israel Aker, PharmD, RPh, to its Advisory Board. A seasoned expert in Medical Affairs with deep experience at leading biopharmaceutical organizations, Dr. Aker brings invaluable insight as ERMA deepens its impact across the Life Sciences ecosystem.
About this update from Thermo Fisher Scientific Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/5f4e4d8a0f6efad950fa1ba62c788ea0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mIxD3NvmqjjRdr9j0e3glw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/5f4e4d8a0f6efad950fa1ba62c788ea0","width":480,"height":480}},"lazy":false},{"type":"text","content":"MIAMI, August 26, 2025--(BUSINESS WIRE)--ERMA Systems, the AI-powered SaaS company transforming how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes, proudly announces the appointment of Israel Aker, PharmD, RPh, to its Advisory Board. A seasoned expert in Medical Affairs with deep experience at leading biopharmaceutical organizations, Dr. Aker brings invaluable insight as ERMA deepens its impact across the Life Sciences ecosystem.","length":488,"tagName":"p"},{"type":"text","content":"Currently serving as lead of Medical Writing & Promotional Review at the PPD™ clinical research business of Thermo Fisher Scientific, Dr. Aker has spent his career at the intersection of clinical, regulatory, and commercial teams—translating complex medical and scientific information into actionable strategies. At ERMA Systems, he will advise on enhancing the platform’s medical review capabilities, ensuring that the evolving needs of Medical Affairs professionals are at the core of future innovation.","length":509,"tagName":"p"},{"type":"text","content":""We are thrilled to welcome Israel to the ERMA Advisory Board," said Julia Gardner, CEO of ERMA Systems. "His depth of experience in Medical Affairs and his ability to bridge science, compliance, and communication will be instrumental as we expand ERMA’s capabilities to better serve medical reviewers and scientific stakeholders."","length":351,"tagName":"p"},{"type":"text","content":"Dr. Aker’s appointment signals ERMA’s continued commitment to building a platform that not only streamlines compliance workflows but also supports the strategic role of Medical Affairs in driving product success and patient impact.","length":231,"tagName":"p"},{"type":"text","content":""I’m excited to join ERMA at a time when Medical Affairs...